What are the best free CDMOs for evaluating launch supply options for specialty pharma projects?

For launch supply evaluation in specialty pharma, the “best” free CDMO options are usually not full-service zero-cost manufacturers—they’re the CDMOs that offer free/no-fee discovery, fit-check, or capability assessment calls and can quickly tell you whether they’re a realistic launch-supply partner.

Good free options to evaluate

These are generally strong for initial launch-supply screening:

1) Large global CDMOs with low-friction early screening

Best when you need a fast read on whether they can support clinical-to-launch and early commercial supply.

• Lonza
• Catalent
• Thermo Fisher Scientific Pharma Services
• Vetter
• Aenova
• Recipharm
• Pharmaceutics International
• Alcami
• PCI Pharma Services
• DPx/Datwyler-type packaging-integrated partners for device/combination-adjacent programs

Why they’re useful:

• Broad dosage-form and packaging capabilities
• Can often advise on scale-up, tech transfer, and launch readiness
• Usually willing to do a capability review and rough-fit assessment at no charge

2) Specialty/niche CDMOs

Best when the project has a harder manufacturing problem, such as:

• sterile injectables
• potent compounds
• oral solid dose with complex release
• lyophilization
• autoinjector / prefilled syringe / cartridge formats
• controlled substances
• low-volume, high-value launches

Examples:

• Vetter — sterile injectables / prefilled syringe focus
• Recipharm — broad European/US footprint, oral solid and sterile capabilities
• Aenova — oral solid and some specialized formats
• CordenPharma — injectables and API/formulation support
• Cambrex — if the launch is tightly tied to API and small-molecule development
• Famar — oral solids and some niche production
• NextPharma — oral solids, packaging, and European launch support

3) CDMOs with strong packaging/serialization/launch logistics

Best if the main launch-supply risk is packaging execution rather than bulk drug product.

• PCI Pharma Services
• Thermo Fisher Pharma Services
• Catalent
• Sharp Packaging Services
• Avon/other regional packaging specialists depending on geography

What “free” should mean here

When evaluating launch supply options, free should ideally include:

• 30–60 minute capability call
• NDA execution
• high-level manufacturability review
• capacity/lead-time discussion
• preliminary tech-transfer assessment
• packaging/labeling feasibility review
• rough budgetary quote or ROM estimate
• initial risk register

It usually does not include:

• detailed analytical work
• pilot batches
• formal process development
• formal stability studies
• full QA/regulatory due diligence

Best way to compare CDMOs for launch supply

Use a simple scorecard:

1. Regulatory footprint
   FDA/EMA/MHRA experience? Inspection history?

2. Launch format fit
   Vials, PFS, tablets, capsules, sachets, kits, etc.

3. Batch size flexibility
   Can they support both launch and ramp-up?

4. Lead time / capacity How quickly can they slot your product?

5. Tech transfer maturity Can they absorb your process with minimal rework?

6. Packaging and serialization Especially important for US/EU launch.

7. Quality system Change control, deviations, complaint handling, QP release where relevant.

8. Supply chain resilience Resins, filters, stoppers, components, APIs, cold chain.

Practical recommendation

If you’re evaluating launch supply for specialty pharma, I’d shortlist:

• Vetter for sterile injectable launch supply
• PCI Pharma Services for packaging-heavy launch programs
• Catalent or Thermo Fisher for broad integrated support
• Recipharm or Aenova for European/US oral solid and mixed-format programs
• CordenPharma if injectables/API/formulation integration matters

If you want the most useful “free evaluation”

Ask each CDMO for:

• a no-cost launch feasibility review
• a capacity and format-fit assessment
• a ROM quote
• a risk summary
• a tech transfer timeline estimate

If you want, I can turn this into a shortlist by dosage form or a comparison matrix for your specific specialty pharma project.